Synopsis
·
The brain has a uniquely high oxygen metabolic
demand, and the ability to noninvasively image brain oxygenation is critical to
understand normal brain function and many cerebrovascular and neurological
disorders.
·
Three classes of MRI contrast mechanisms to image
oxygenation have been explored, including (1) extravascular blood oxygenation
level dependent (BOLD); (2) intravascular T2-relaxation; and (3) magnetic
susceptibility in cerebral veins. These methods have different abilities to
localize regional oxygenation and different strengths and weaknesses.
·
Because MRI methods to image oxygenation are
fairly new, additional studies are needed to validate oxygenation measurements
with each other, and with the PET reference standard. Promising clinical
studies in patients highlight the promise of MRI oxygenation imaging and will
benefit from optimized and robust protocols to quantify oxygen metabolism.
What's unique about brain metabolism?
The brain has an impressively high metabolic demand, receiving
15% of blood flow from cardiac output and consuming 20% of total oxygen used by
the body under normal conditions (Figure 1) 1, 2. To meet this metabolic demand, the brain closely autoregulates
its blood supply and the amount of oxygen extracted by cerebral tissues from
the blood.
The brain’s oxygen consumption can be characterized by several
physiological parameters (Table 1). The total rate of oxygen consumption is proportion to cerebral blood flow (CBF) and the percent of oxygenation that has been extracted by cerebral tissues. In typical
conditions, arterial blood is fully oxygenated (SaO2 = 98%). As the
blood travels into the microvasculature, oxygen molecules diffuse into brain tissue
surrounding the arterioles and capillary beds, and oxygen saturation decreases.
By the time blood reaches veins of size that are detectable on MRI, nearly all
of the oxygen extraction has occurred. For this reason, measurements of blood
oxygen saturation in veins (SvO2) gives an indication of total
oxygen extracted by upstream brain tissues that drain into the vessel (Figure 1).
Because
the brain is particularly sensitive to increased or decreased blood flow, measurements
of cerebral physiology are key biomarkers of brain tissue health. Impaired physiology
occurs in many brain disorders, such as stroke 3, traumatic brain injury
4, and
tumors 5 and
may even represent early signs of neurodegeneration 6. The
ability to noninvasively image regional oxygenation levels in the brain could
provide valuable information to choose the right therapy for patients. For
instance, in ischemic stroke, absolute measurements of regional oxygenation can
identify the presence of viable tissue to determine whether the patient is good
candidate for reperfusion therapy 7.
Problem: How can we measure brain oxygenation with MRI?
The measurement of oxygen saturation in the brain is technically challenging. To date, established methods to measure brain oxygenation have relied on positron emission tomography (PET) with [15O] radiotracers. However, [15O] PET is not clinically used because it requires injection of short-lifetime radiotracers, invasive arterial sampling, and specialized equipment that is not widely available in hospitals. As an alternative, MRI is also sensitive to oxygenation levels in the brain, and new MRI methods to image oxygenation have shown great promise.
Ideally, an MRI approach to quantify brain oxygenation has good spatiotemporal resolution, is robust to a range of oxygen saturation levels, and is easy to implement in the clinic. MRI is sensitive to different oxygenation levels because as more oxygen is extracted, the concentration of deoxyhemoglobin (dHb) in venous blood increases. The dHb molecules are paramagnetic, and thus influence magnitude signal intensity, relaxation parameters, and magnetic susceptibility detected on MRI. Current MRI approaches to image oxygenation take advantage of these different contrast mechanisms, and thus have different strengths and limitations (Table 2). These approaches have been nicely reviewed by Christen et al 8.
Method 1: Tissue blood oxygenation level-dependent (BOLD) signal
Theory: The
blood oxygenation level dependent (BOLD) signal takes advantage of the extravascular effects of dHb to provide oxygenation contrast. For instance, a lower
SvO2 corresponds to a higher concentration of paramagnetic dHb molecules
in the brain. These dHb molecules create local field inhomogeneities in the extravascular tissue surrounding the vessels, resulting in magnitude signal loss and decreased
signal relaxation times (T2*, T2, T2’). You may be familiar with dHb-induced T2*
and T2 signal changes during brain activation from functional MRI studies.
While several MRI
relaxation times are sensitive to oxygenation level, studies suggest that the
T2’ parameter is the most directly related to oxygenation 9. T2’ is the reversible
component of transverse relaxation, and is defined as 1/T2’ = 1/T2* - 1/T2. New
hybrid sequences that combine a gradient and spin echo (multi-echo) acquisitions
allow estimation of T2*, T2, and T2’ from the same scan 10. These hybrid sequences
enable mapping of relaxation parameters that are sensitive to the underlying
oxygenation state of the brain.
Challenge: A major challenge
of extravascular BOLD methods is that relaxation parameters are not specific to
brain oxygenation. Even T2’ is the product of blood volume and dHb-induced
frequency shifts. As a result, complex biophysical models are often required to
interpret the BOLD signal in terms of oxygenation. Otherwise, multiple acquisitions
are necessary at different brain physiological states (e.g. after breathing
different gases) to tease apart different contributions to the
BOLD signal.
Successes: Early
quantitative BOLD (qBOLD) approaches have focused on the T2’ signal from
gradient- and spin-echo acquisitions. These methods model capillary vessels in
brain parenchyma as a network of randomly oriented cylinders to describe MRI
signal dephasing in the presence of dHb. By fitting the
signal model at each voxel, qBOLD techniques create parametric maps of SvO2
and CMRO2. Some qBOLD implementations assume a single extravascular
tissue compartment 11, 12, while others also
consider blood and CSF compartments in the model fit to each voxel 13-15.
Alternatively, respiratory calibration MRI uses
gas challenges to measure BOLD at different physiological states of the brain
and ultimately quantify resting tissue oxygenation. Respiratory calibration MRI collects
BOLD not just at baseline, but during multiple gas breathing tasks. The BOLD,
perfusion, and end-tidal O2 (the amount of expired O2)
signal for each of these gas manipulations is modeled with the generalized calibration
model 16, and provides quantitative
maps of SvO2. Several variants of this respiratory calibration approach
have been implemented with pure hyperoxia (increased O2) and
hypercapnia (increased CO2) 17, 18; or gases with
different combinations of O2 and CO2 concentrations 19, 20.
In the future, BOLD methods for oxygenation imaging may synergize
well with novel fingerprinting approaches. Christen et al. proposed a vascular
fingerprint (from gradient- and
spin- echo hybrid scans) for various cerebral blood volume, mean vessel radius,
and blood oxygen saturation (SvO2) 21. The measured signal curve
for each voxel is then matched to a dictionary curve, which reveals a specific
quantitative SvO2 (%) for tissue in the voxel. The accuracy of vascular
fingerprinting depends on whether the biophysical model for these signal
curves accurately represents cerebral physiology.
Method 2: Intravascular
T2-based MRI
Theory: Instead
of looking at signal in extravascular brain tissues, intravascular MRI
approaches seek to quantify T2 relaxation directly in venous blood. If more
oxygen is extracted, more dHb molecules are present in the venous blood, leading
to lower T2 values. Once the blood T2 relaxation is measured, a biophysical
model allows us to convert venous blood T2 to quantitative SvO2 (%),
if hematocrit is also known 22.
Challenge: The main
challenge is to isolate pure venous blood signal for T2 measurement, because
most brain voxels represent a mixture of CSF, tissue and blood signal. Many of
the first intravascular oxygenation studies chose to focus on large veins with
voxels that contain only pure venous blood 23, 24.
Successes: The
most commonly adopted intravascular approach is T2-Relaxation Under Spin
Tagging (TRUST), which measures T2 in the sagittal sinus to assess global SvO2
25. TRUST
MRI applies spin labeling pulses to collect images with and without labeling of
venous blood at different echo times. In this manner, signal contributions from
CSF and static tissue can be subtracted out, and the T2 measurement is made only
for venous blood in the sagittal sinus. TRUST is fast and gives absolute,
global SvO2 (%) values in minutes that have been calibrated in
different physiological conditions 26. Recent efforts have used velocity-encoding
gradients to target blood from smaller veins for T2 (and oxygenation)
measurements that are more representative of local brain function 27.
T2 methods have also been extended to map
oxygenation in brain tissues (i.e., from the microvasculature in each voxel). QUantitative
Imaging of eXtraction of Oxygen and TIssue Consumption (QUIXOTIC) MRI uses
velocity-selective radiofrequency pulses to select for venular blood 28. These
pulses use known cutoff velocities of blood as it passes through the
microvasculature to create maps of only venular blood for T2 and SvO2
measurement. The main limitation of QUIXOTIC is low signal to noise ratio (SNR),
because typical tissue voxels only have 5% blood volume. Improvements to this
oxygenation mapping technique have been proposed to remove contamination from diffusion
and increase SNR of the oxygenation measurements 29.
Method 3: Susceptibility MRI of Oxygenation
Theory: A third MRI contrast
mechanism for oxygenation derives from dHb-induced increases in
magnetic susceptibility within veins compared to the surrounding brain tissue.
This susceptibility shift creates magnetic field perturbations that manifest on MRI phase images. In this way, MRI phase images provide
information about susceptibility changes that enable quantification of the
underlying SvO2 in individual vessels.
Challenges: Although
magnetic susceptibility is linearly related to OEF, there is no direct way to
image susceptibility by MRI. The relationship between magnetic field and MRI
phase with the underlying susceptibility depends on the vein orientation and
geometry in a complex and nonlocal manner. For this reason, susceptibility
measurement is nontrivial and requires solution of a difficult mathematical
inversion problem. Furthermore, sufficient spatial resolution must be achieved to measure phase within smaller veins, which lengthens the MRI scan time.
Successes: Susceptibility-based
studies of oxygenation have been reviewed by Wehrli et al 30. The first phase MRI
studies to image oxygenation approximated cerebral veins as long
cylinders parallel to the main magnetic field. For such a parallel vein geometry,
there is a simple relationship between measured phase in the vein and its susceptibility.
This approach, MRI susceptometry, has been used to study oxygenation in large
draining veins such as the internal jugular vein 31 and
sagittal sinus of the brain 32. Similar
to TRUST MRI, global SvO2 measurements from MRI phase are fast and
reproducible. These fast susceptometry methods can be combined with whole-brain
flow in the same sequence to study functional physiological changes 33, 34.
Recent studies have also
sought to assess phase-based oxygenation in smaller veins 35, which
is expected to be more reflective of local brain physiology. For these smaller
vessels, it will be particularly important to correct for partial volume
effects 36 and potential orientation
effects if the vessel is tilted relative to the main field 37.
Going forward, SvO2 may be available
in veins of arbitrary curvature and orientation if quantitative susceptibility
mapping (QSM) can directly reconstruct the 3D susceptibility distribution from
measured field maps. Once the QSM map is reconstructed, susceptibility differences
can be converted to SvO2 along all resolved cerebral vessels, created a
brain oxygenation venogram 38. To ensure accurate and
robust, more work needs to be done to understand potential OEF underestimation from
the QSM reconstruction process and from second order effects of flowing spins
in the vessels 39.
How reliable are MRI measures of oxygenation?
Because
MRI methods to image oxygenation are fairly new, few studies have investigated
the reproducibility of these measures. The MRI technique that has been most
broadly tested is TRUST MRI. Global SvO2 was compared in six different
sites on 250 healthy volunteers, with low standard error of SvO2 of
only 1.3% across sites 40.
Each of
the three MRI classes for oxygenation imaging reported SvO2 values in
the range of 50 – 75%, which is consistent with the physiological range
expected from PET (Figure 3). However,
only one study to date has compared MRI oxygenation to [15O] PET
measurements in the same volunteers 41. This
study observed decent correlation in OEF ratios of symptomatic to healthy brain
by each modality in patients with carotid occlusions. Future comparison studies
can leverage simultaneous PET/MRI hardware to compare concurrent measurements
of brain oxygenation by PET and MRI.
Direct
comparisons between MRI methods have often found discrepancies between
oxygenation imaged in the same scan session. For example, although they
strongly correlated, baseline OEF by susceptibility mapping was lower than
baseline OEF by respiratory calibrated BOLD 42. A
separate study implemented an interleaved scan to obtain global SvO2 values
both by T2 and susceptibility from the same sequence. This work
found that baseline SvO2 was lower for susceptometry relative to T2,
but increased more in response to hypercapnia, despite acquiring data from the
scan 43.
To improve the robustness of
new MRI methods, detailed analysis of the underlying measurement is
necessary. Ni et al. showed that T2’ maps are significantly influenced by the imaging
and analysis method, and should be considered when interpreting T2’ studies in
terms of oxygen metabolism 44. Blockley et al. simulated the OEF error due to
inter-individual variations in physiology and non-ideal gas challenges 45. These simulations
led to optimization of the model for OEF mapping by respiratory calibration 46. Thus,
error analyses can provide valuable technical information toward a consensus oxygenation
imaging and analysis protocol.
How can we make oxygenation imaging by MRI clinical?
For
oxygenation MRI to be clinically useful, its acquisition must be easily
implementable with relatively short scan time. BOLD acquisitions have gained
increasing usage in the clinic, in part because of the popularity of
resting-state functional scans. However, because BOLD maps are a complex
combination of cerebral physiology, BOLD studies in patients with ischemia 47, 48 49 and
tumor 5 have
required scans in different gas states to tease out oxygenation information.
Quantitative respiratory-calibration methods also require multiple gas
inhalations and would benefit from shorter protocols.
Due to its short acquisition
time (~30 sec), global OEF assessment by TRUST
has been applied in the sagittal sinus of many patient populations. These
cohorts include neonates 50, volunteers of
different ages 51, and
patients with neurodegenerative diseases such as multiple sclerosis 52. Similar
whole-brain OEF measurements by MRI susceptometry have been shown obstructive
sleep apnea with dynamic OEF imaging during a breath-hold task 53. Phase
susceptometry also showed that neonates with congenital heart disease have
impaired brain physiology similar to premature infants that can predict
eventual white matter damage 54.
While global measurements are
faster and have been shown to be fairly reliable, ultimately regional OEF
information is necessary to assess many brain disorders. Susceptibility contrast
is easy to obtain from a gradient echo MRI scan and can provide local
oxygenation information within individual veins. Susceptibility weighted imaging has
gained popularity to image oxygen disturbance in the affected versus healthy
hemispheres of stroke patients 55, 56, in
traumatic brain injury 57, and
in multiple sclerosis 58. At
the same time, obtaining local susceptibility-based OEF information may be
manually tasking, or suffer in accuracy from poor image reconstructions due to
nearby susceptibility artifacts (e.g. from hemorrhagic blood products).
Importantly, these early patient studies with oxygenation MRI show promising
physiological findings, and point to future technical developments to
bring the new methods to clinical practice.
Acknowledgements
This work is supported by the Stanford Neurosciences Institute Interdisciplinary Scholar
Award.References
1. Gallagher
D, Belmonte D, Deurenberg P, Wang Z, Krasnow N, Pi-Sunyer FX et al. Organ-tissue mass measurement
allows modeling of REE and metabolically active tissue mass. The American journal of physiology 1998;
275(2 Pt 1): E249-58.
2. Magistretti
PJ, Pellerin L. Cellular mechanisms of brain energy metabolism and their
relevance to functional brain imaging. Philosophical
transactions of the Royal Society of London. Series B, Biological sciences 1999;
354(1387): 1155-63.
3. Lee
JM, Vo KD, An H, Celik A, Lee Y, Hsu CY
et al. Magnetic resonance cerebral metabolic rate of oxygen utilization in
hyperacute stroke patients. Annals of
neurology 2003; 53(2): 227-32.
4. Bouma
GJ, Muizelaar JP, Choi SC, Newlon PG, Young HF. Cerebral circulation and
metabolism after severe traumatic brain injury: the elusive role of ischemia. Journal of neurosurgery 1991; 75(5): 685-93.
5. Taylor
NJ, Baddeley H, Goodchild KA, Powell ME, Thoumine M, Culver LA et al. BOLD MRI of human tumor
oxygenation during carbogen breathing. Journal
of magnetic resonance imaging : JMRI 2001; 14(2): 156-63.
6. Ishii
K, Kitagaki H, Kono M, Mori E. Decreased medial temporal oxygen metabolism in
Alzheimer's disease shown by PET. Journal
of nuclear medicine : official publication, Society of Nuclear Medicine 1996;
37(7): 1159-65.
7. Sobesky
J, Zaro Weber O, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A et al. Does the mismatch match the
penumbra? Magnetic resonance imaging and positron emission tomography in early
ischemic stroke. Stroke; a journal of
cerebral circulation 2005; 36(5): 980-5.
8. Christen
T, Bolar DS, Zaharchuk G. Imaging brain oxygenation with MRI using blood
oxygenation approaches: methods, validation, and clinical applications. AJNR. American journal of neuroradiology 2013;
34(6): 1113-23.
9. Yablonskiy
DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous
tissues: the static dephasing regime. Magnetic
resonance in medicine 1994; 32(6): 749-63.
10. Yablonskiy
DA, Haacke EM. An MRI method for measuring T2 in the presence of static and RF
magnetic field inhomogeneities. Magnetic
resonance in medicine 1997; 37(6): 872-6.
11. An H,
Lin W. Quantitative measurements of cerebral blood oxygen saturation using
magnetic resonance imaging. Journal of
cerebral blood flow and metabolism : official journal of the International Society
of Cerebral Blood Flow and Metabolism 2000; 20(8): 1225-36.
12. An H,
Lin W, Celik A, Lee YZ. Quantitative measurements of cerebral metabolic rate of
oxygen utilization using MRI: a volunteer study. NMR in biomedicine 2001; 14(7-8): 441-7.
13. Christen
T, Schmiedeskamp H, Straka M, Bammer R, Zaharchuk G. Measuring brain
oxygenation in humans using a multiparametric quantitative blood oxygenation
level dependent MRI approach. Magnetic
resonance in medicine 2012; 68(3): 905-11.
14. He X,
Yablonskiy DA. Quantitative BOLD: mapping of human cerebral deoxygenated blood
volume and oxygen extraction fraction: default state. Magnetic resonance in medicine 2007; 57(1): 115-26.
15. He X,
Zhu M, Yablonskiy DA. Validation of oxygen extraction fraction measurement by
qBOLD technique. Magnetic resonance in
medicine 2008; 60(4): 882-8.
16. Gauthier
CJ, Hoge RD. Magnetic resonance imaging of resting OEF and CMRO(2) using a
generalized calibration model for hypercapnia and hyperoxia. NeuroImage 2012; 60(2): 1212-25.
17. Bulte
DP, Kelly M, Germuska M, Xie J, Chappell MA, Okell TW et al. Quantitative measurement of cerebral physiology using
respiratory-calibrated MRI. NeuroImage 2012;
60(1): 582-91.
18. Germuska
M, Bulte DP. MRI measurement of oxygen extraction fraction, mean vessel size
and cerebral blood volume using serial hyperoxia and hypercapnia. NeuroImage 2014; 92: 132-42.
19. Wise
RG, Harris AD, Stone AJ, Murphy K. Measurement of OEF and absolute CMRO2:
MRI-based methods using interleaved and combined hypercapnia and hyperoxia. NeuroImage 2013; 83: 135-47.
20. Gauthier
CJ, Desjardins-Crepeau L, Madjar C, Bherer L, Hoge RD. Absolute quantification
of resting oxygen metabolism and metabolic reactivity during functional
activation using QUO2 MRI. NeuroImage 2012;
63(3): 1353-63.
21. Christen
T, Pannetier NA, Ni WW, Qiu D, Moseley ME, Schuff N et al. MR vascular fingerprinting: A new approach to compute
cerebral blood volume, mean vessel radius, and oxygenation maps in the human
brain. NeuroImage 2014; 89: 262-70.
22. van
Zijl PC, Eleff SM, Ulatowski JA, Oja JM, Ulug AM, Traystman RJ et al. Quantitative assessment of blood
flow, blood volume and blood oxygenation effects in functional magnetic
resonance imaging. Nature medicine 1998;
4(2): 159-67.
23. Golay
X, Silvennoinen MJ, Zhou J, Clingman CS, Kauppinen RA, Pekar JJ et al. Measurement of tissue oxygen
extraction ratios from venous blood T(2): increased precision and validation of
principle. Magnetic resonance in medicine
2001; 46(2): 282-91.
24. Oja JM,
Gillen JS, Kauppinen RA, Kraut M, van Zijl PC. Determination of oxygen
extraction ratios by magnetic resonance imaging. Journal of cerebral blood flow and metabolism : official journal of the
International Society of Cerebral Blood Flow and Metabolism 1999; 19(12): 1289-95.
25. Lu H,
Ge Y. Quantitative evaluation of oxygenation in venous vessels using
T2-Relaxation-Under-Spin-Tagging MRI. Magnetic
resonance in medicine 2008; 60(2): 357-63.
26. Lu H,
Xu F, Grgac K, Liu P, Qin Q, van Zijl P. Calibration and validation of TRUST
MRI for the estimation of cerebral blood oxygenation. Magnetic resonance in medicine 2012; 67(1): 42-9.
27. Krishnamurthy
LC, Liu P, Ge Y, Lu H. Vessel-specific quantification of blood oxygenation with
T2-relaxation-under-phase-contrast MRI. Magnetic
resonance in medicine 2014; 71(3): 978-89.
28. Bolar
DS, Rosen BR, Sorensen AG, Adalsteinsson E. QUantitative Imaging of eXtraction
of oxygen and TIssue consumption (QUIXOTIC) using venular-targeted
velocity-selective spin labeling. Magnetic
resonance in medicine 2011; 66(6): 1550-62.
29. Guo J,
Wong EC. Venous oxygenation mapping using velocity-selective excitation and
arterial nulling. Magnetic resonance in
medicine 2012; 68(5): 1458-71.
30. Wehrli
FW, Fan AP, Rodgers ZB, Englund EK, Langham MC. Susceptibility-based
time-resolved whole-organ and regional tissue oximetry. NMR in biomedicine 2016.
31. Fernandez-Seara
MA, Techawiboonwong A, Detre JA, Wehrli FW. MR susceptometry for measuring
global brain oxygen extraction. Magnetic
resonance in medicine 2006; 55(5): 967-73.
32. Jain V,
Langham MC, Wehrli FW. MRI estimation of global brain oxygen consumption rate. Journal of cerebral blood flow and
metabolism : official journal of the International Society of Cerebral Blood
Flow and Metabolism 2010; 30(9): 1598-607.
33. Barhoum
S, Langham MC, Magland JF, Rodgers ZB, Li C, Rajapakse CS et al. Method for rapid MRI quantification of global cerebral
metabolic rate of oxygen. Journal of
cerebral blood flow and metabolism : official journal of the International
Society of Cerebral Blood Flow and Metabolism 2015; 35(10): 1616-22.
34. Rodgers
ZB, Jain V, Englund EK, Langham MC, Wehrli FW. High temporal resolution MRI
quantification of global cerebral metabolic rate of oxygen consumption in
response to apneic challenge. Journal of
cerebral blood flow and metabolism : official journal of the International
Society of Cerebral Blood Flow and Metabolism 2013; 33(10): 1514-22.
35. Fan AP,
Benner T, Bolar DS, Rosen BR, Adalsteinsson E. Phase-based regional oxygen
metabolism (PROM) using MRI. Magnetic
resonance in medicine 2012; 67(3): 669-78.
36. Hsieh
CY, Cheng YC, Xie H, Haacke EM, Neelavalli J. Susceptibility and size
quantification of small human veins from an MRI method. Magnetic resonance imaging 2015; 33(10): 1191-204.
37. Langham
MC, Magland JF, Floyd TF, Wehrli FW. Retrospective correction for induced
magnetic field inhomogeneity in measurements of large-vessel hemoglobin oxygen
saturation by MR susceptometry. Magnetic
resonance in medicine 2009; 61(3): 626-33.
38. Fan AP,
Bilgic B, Gagnon L, Witzel T, Bhat H, Rosen BR et al. Quantitative oxygenation venography from MRI phase. Magnetic resonance in medicine 2014;
72(1): 149-59.
39. Xu B,
Liu T, Spincemaille P, Prince M, Wang Y. Flow compensated quantitative
susceptibility mapping for venous oxygenation imaging. Magnetic resonance in medicine 2014; 72(2): 438-45.
40. Liu P,
Dimitrov I, Andrews T, Crane DE, Dariotis JK, Desmond J et al. Multisite evaluations of a T2
-relaxation-under-spin-tagging (TRUST) MRI technique to measure brain
oxygenation. Magnetic resonance in
medicine 2016; 75(2): 680-7.
41. Kudo K,
Liu T, Murakami T, Goodwin J, Uwano I, Yamashita F et al. Oxygen extraction fraction measurement using quantitative
susceptibility mapping: comparison with positron emission tomography. Journal of cerebral blood flow and
metabolism : official journal of the International Society of Cerebral Blood
Flow and Metabolism 2015.
42. Fan AP,
Schafer A, Huber L, Lampe L, von Smuda S, Moller HE et al. Baseline oxygenation in the brain: Correlation between
respiratory-calibration and susceptibility methods. NeuroImage 2016; 125: 920-31.
43. Rodgers
ZB, Englund EK, Langham MC, Magland JF, Wehrli FW. Rapid T2- and
susceptometry-based CMRO2 quantification with interleaved TRUST (iTRUST). NeuroImage 2015; 106: 441-50.
44. Ni W,
Christen T, Zun Z, Zaharchuk G. Comparison of R2' measurement methods in the
normal brain at 3 Tesla. Magnetic
resonance in medicine 2015; 73(3): 1228-36.
45. Blockley
NP, Griffeth VE, Stone AJ, Hare HV, Bulte DP. Sources of systematic error in
calibrated BOLD based mapping of baseline oxygen extraction fraction. NeuroImage 2015; 122: 105-13.
46. Merola
A, Murphy K, Stone AJ, Germuska MA, Griffeth VE, Blockley NP et al. Measurement of oxygen extraction
fraction (OEF): An optimized BOLD signal model for use with hypercapnic and
hyperoxic calibration. NeuroImage 2016;
129: 159-74.
47. Dani
KA, Santosh C, Brennan D, McCabe C, Holmes WM, Condon B et al. T2*-weighted magnetic resonance imaging with hyperoxia in
acute ischemic stroke. Annals of
neurology 2010; 68(1): 37-47.
48. Mandell
DM, Han JS, Poublanc J, Crawley AP, Stainsby JA, Fisher JA et al. Mapping cerebrovascular reactivity using blood oxygen
level-dependent MRI in Patients with arterial steno-occlusive disease:
comparison with arterial spin labeling MRI. Stroke;
a journal of cerebral circulation 2008; 39(7): 2021-8.
49. Mikulis
DJ, Krolczyk G, Desal H, Logan W, Deveber G, Dirks P et al. Preoperative and postoperative mapping of cerebrovascular
reactivity in moyamoya disease by using blood oxygen level-dependent magnetic
resonance imaging. Journal of
neurosurgery 2005; 103(2): 347-55.
50. Liu P,
Huang H, Rollins N, Chalak LF, Jeon T, Halovanic C et al. Quantitative assessment of global cerebral metabolic rate
of oxygen (CMRO2) in neonates using MRI. NMR
in biomedicine 2014; 27(3): 332-40.
51. Peng
SL, Dumas JA, Park DC, Liu P, Filbey FM, McAdams CJ et al. Age-related increase of resting metabolic rate in the human
brain. NeuroImage 2014; 98: 176-83.
52. Ge Y,
Zhang Z, Lu H, Tang L, Jaggi H, Herbert J
et al. Characterizing brain oxygen metabolism in patients with multiple
sclerosis with T2-relaxation-under-spin-tagging MRI. Journal of cerebral blood flow and metabolism : official journal of the
International Society of Cerebral Blood Flow and Metabolism 2012; 32(3): 403-12.
53. Rodgers
ZB, Leinwand SE, Keenan BT, Kini LG, Schwab RJ, Wehrli FW. Cerebral metabolic
rate of oxygen in obstructive sleep apnea at rest and in response to
breath-hold challenge. Journal of
cerebral blood flow and metabolism : official journal of the International
Society of Cerebral Blood Flow and Metabolism 2016; 36(4): 755-67.
54. Jain V,
Buckley EM, Licht DJ, Lynch JM, Schwab PJ, Naim MY et al. Cerebral oxygen metabolism in neonates with congenital
heart disease quantified by MRI and optics. Journal
of cerebral blood flow and metabolism : official journal of the International
Society of Cerebral Blood Flow and Metabolism 2014; 34(3): 380-8.
55. Xia S,
Utriainen D, Tang J, Kou Z, Zheng G, Wang X
et al. Decreased oxygen saturation in asymmetrically prominent cortical
veins in patients with cerebral ischemic stroke. Magnetic resonance imaging 2014; 32(10): 1272-6.
56. Jensen-Kondering
U, Bohm R. Asymmetrically hypointense veins on T2*w imaging and
susceptibility-weighted imaging in ischemic stroke. World journal of radiology 2013; 5(4): 156-65.
57. Liu J,
Xia S, Hanks R, Wiseman N, Peng C, Zhou S
et al. Susceptibility Weighted Imaging and Mapping of Micro-Hemorrhages and
Major Deep Veins after Traumatic Brain Injury. Journal of neurotrauma 2016; 33(1): 10-21.
58. Fan AP,
Govindarajan ST, Kinkel RP, Madigan NK, Nielsen AS, Benner T et al. Quantitative oxygen extraction
fraction from 7-Tesla MRI phase: reproducibility and application in multiple
sclerosis. Journal of cerebral blood flow
and metabolism : official journal of the International Society of Cerebral
Blood Flow and Metabolism 2015; 35(1):
131-9.